Arjun Prasad Email & Phone Number

Boston , Ma , Us

Lead the restructured US Commercial organization that includes Sales & Marketing functions (see below for more details), as well as US Market Access functions (Payer Marketing, Government Pricing & Contracting, Trade & Distribution, and National Accounts team). Member of the U.S. Strategic Council responsible for enterprise-wide decision making on topics such as strategic planning, organizational growth and resource planning. The Council is responsible for ensuring that the organization meets and exceeds both its near-term targets, as well as delivers on the longer-term organizational strategy and objectives.

Boston , Ma , Us

Lead 100+ person organization responsible for all U.S. Commercial activities, including: • Sales and nurse education for asparaginase (Oncaspar and Asparlas) for Acute Lymphoblastic Leukemia (ALL)• Sales for Tibsovo in mIDH1+ Acute Myeloid Leukemia (AML) and Cholangiocarcinoma (CCA) as well as Idhifa for mIDH2+ AML• Brand Marketing and Key Customer Marketing• Commercial Operations, Insights & Analytics including Forecasting, Market Research, Competitive Intelligence, Sales Operations, Marketing Operations, and TrainingSignificant organizational change leadership to integrate two organizations, following Servier’s acquisition of the Agios oncology portfolio and team in April 2021. This included:• Rapid assessment of the existing Commercial model • Implementing structural and process changes to optimize teams for future growth• Minimizing attrition with a focus on internal talent retention and developmentKey member of US Executive Leadership Team responsible for broader success of the U.S. business and achievement of organizational goals.

Cambridge, Ma, Us

Lead the Oncology Marketing team, responsible for key activities including:- IDH brand marketing for AML and cholangiocarcinoma- Field Marketing/Thought Leader Liasons- Oncology Pipeline Marketing (including TIBSOVO in myelodisplastic syndrome, vorasidenib for low grade glioma, and AG-270 for pancreatic and lung cancers).Lead Commercial Operations & Analytics team supporting the Agios portfolio across all Oncology and Rare Genetic Disease programs. Team responsibilities including Sales Operations, Strategic Insights, Market Research, and Competitive Intelligence.

Cambridge, Ma, Us

Cambridge, Ma, Us

Lead team responsible for the TIBSOVO brand marketing in Acute Myeloid Leukemia, Field Marketing/Thought Leader Liasons, and Oncology Pipeline Marketing (including TIBSOVO in myelodisplastic syndrome, vorasidenib for low grade glioma, and AG-270 for pancreatic and lung cancers). Commercial lead on Agios oncology program teams, and commercial representative on joint steering and commercial committees with numerous diagnostic and co-commercialization partners.

South San Francisco, California, Us

- Lead and manage an 8-person sales team responsible for both Actemra® as well as Rituxan® Immunology sales across five states and 7 autoimmune disease states. - Provide sales coaching and feedback to exceed sales goals, as well as opportunities for professional development and team leadership opportunities. - Manage functional sales partner relationships across the division, including Field Reimbursment Managers, Thought Leader Liasons, Field Program Managers, and Clinical Coordinators.-Liase with Marketing and home office functions to inform strategic direction, and optimize pull through of strategies and sales materials. Member of national Competitive Excellence Leadership Team, responsible for developing and implementing best-practices across the franchise.

South San Francisco, California, Us

- US marketing and cross-functional team lead responsible for successful launch of ALECENSA®. - Involvement all aspects of launch preparation, including positioning, strategies, competitive differentiation and managed care support- US Commercial representative on global Life Cycle Team, with responsibility for US Package Insert drafting, label negotiation, as well as global supply chain management. - Close partnership with sales leadership to determine sales force prioritization, selling direction and incentive compensation for new product, as well as input into development of launch strategies, materials and sales training- Also lead separate team responsible for portfolio-wide activities to shape the lung cancer market: increasing lung cancer treatment rates, as well as optimizing screening- Launched unbranded education program to drive referral and treatment rates with multi-disciplinary HCP audience- Identified strategies and tactics to enhance lung cancer screeening- Lead identification of novel technologies and external partnerships to optimize screening and treatment- Lead cross-functional teams including Advocacy Relations, Corporate Relations, Commercial Partnering, and Market Analysis- Lead 3-person team of Sr. Product Managers, responsible for execution of strategy and tactics across ALECENSA® and Lung Disease Strategy initiatives

South San Francisco, California, Us

- Promotions Lead, with responsibility for all HCP personal and non-personal marketing. Management of Ad Agency, Promotional Review Committee (Legal and Commercial Regulatory), as well as sales force liason. - Led development and roll-out of promotional messages, brand campaign, and all core print materials- Responsible for digital market plan, including website, iDetail, eDetail and branded communications (eBlasts, SEO etc.) - Managed 4 field-based sales representatives to successfully develop and roll-out peer-to-peer speaker program

South San Francisco, California, Us

- Lead 5-person team responsible for all planning activites for dalcetrapib (Ph. III cardiovascular molecule). Key activities include:- Hire, manage and develop four direct reports- US Commercial representative on global launch task-force, - Lead all strategic planning efforts, including disease state campaign, product positioning, segmentation, launch readiness, etc.- Oversee all commercial valuations for molecule, including Long Range Planning, Lifecycle Plan, Business Development valuations etc.

South San Francisco, California, Us

Led two-person team responsible for all planning activities for Herceptin (HER2+ breast cancer and HER2+ gastric cancer).Key activities include:- Manage and develop a direct report- Support launches for new label extension (TCH) as well as indication (HER2+ gastric cancer)- Lead strategic planning activities, including quarterly performance tracking, sales reconciliation, remaining opportunity assessments, diagnostic testing strategy etc.- Lead all commercial valuations for molecule, including epidemiology and commercial planning updates

Refugee Health & Humanitarian Crisis Federal Policy

Washington, District Of Columbia, Us

Rural Public Health Volunteer, Ecuador

Competitive Intelligence with a focus on pharmaceuticals and biotech.

Mph/Mba

Ba

Education record